Subscribe to our Newsletters !!

    vacciantion

    BDR Pharma inks permit concurrence with DRDO to deliver COVID-19 drug 2-DG

    BDR Pharma on Monday said it has inked a licensing pact with the Defence Research and Development Organisation (DRDO) to manufacture, distribute, and market COVID-19 drug 2-Deoxy-D-Glucose (2-DG) in the country. BDR Pharma has inked a pact with the Defence Research and Development Establishment (DRDE) and the Institute of Nuclear Medicine and Allied Sciences (INMAS)